Cell Analysis Market Size, Share, and Industry Report [2031]
Cell Analysis Market Size, Share, and Industry Report [2031]
Segments - Cell Analysis Market by Techniques (High Content Screening, Spectrophotometry, Microscopy, Cell Microarrays, PCR, Flow Cytometry, and Others), Products & Services (Service, Software, Accessories, Instruments, and Reagents & Consumables), Process (Single-Cell Analysis, Target Identification & Validation, Cell Structure Study, Cell Interaction, Cell Counting & Quality Control, Cell Proliferation, Cell Signaling Pathways/Signal Transduction, Cell Viability, and Cell Identification), End-users (Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, Pharmaceutical & Biotechnology Companies, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
Upcoming
| Report ID :HC-4427
| 4.1 Rating
| 69 Reviews
| 198 Pages
| Format :
Report Description
The cell analysis market size was valued at USD 17.7 billion in 2021 and is projected to reach USD 28.9 billion by 2030, expanding at a CAGR of around 10% during the forecast period, 2022 – 2030. The growth of the market is attributed to the increased cancer incidence and rising healthcare business.
The study of cells separated from tissues in multicellular and unicellular organisms is referred to as cell analysis. Cellular analysis plays an important role in protein identification epigenomics, gene identification, and other life science-related areas. The study of an organism's genetic and phonotypical traits is a natural process. Cellular analysis is used to assess and quantify cell number, cell condition, cell health & viability, proliferation, as well as chemical and cell-mediated toxicity.
Market Trends, Drivers, Restraints, and Opportunities
- Cell-based assays are becoming popular in drug development, which is projected to drive the market during the forecast period.
- Development of technologically advanced products is anticipated to fuel the market in the coming years.
- Increasing hospitals and diagnostic laboratories in the developing nations is estimated to boost the market.
- Increased government investments in the life sciences industry are expected to propel the market during the projected period.
- High cost of the cell analysis instruments is expected to hamper the market growth.
- Complex and time-consuming regulatory standards are anticipated to hinder the market growth.
- Rapid expansion of biopharmaceutical and biotechnological enterprises is projected to create immense opportunities for the market players.
Scope of the Report
The report on the global cell analysis market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Cell Analysis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2021 |
|
Historic Data |
2019–2020 |
|
Forecast Period |
2022 – 2030 |
|
Segmentation |
Techniques (High Content Screening, Spectrophotometry, Microscopy, Cell Microarrays, PCR, Flow Cytometry, and Others), Products & Services (Service, Software, Accessories, Instruments, and Reagents & Consumables), Process (Single-Cell Analysis, Target Identification & Validation, Cell Structure Study, Cell Interaction, Cell Counting & Quality Control, Cell Proliferation, Cell Signaling Pathways/Signal Transduction, Cell Viability, and Cell Identification), End-users (Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, Pharmaceutical & Biotechnology Companies, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Illumina; 10x Genomics; Corning Incorporated; QIAGEN; CELLINK; Tecan Trading AG; PerkinElmer; Promega Corporation; Meiji Techno; Creative Bioarray; Cell Biolabs; NanoCellect Biomedical; Fluidigm Corporation; BioStatus Limited; Bio-Rad Laboratories; Miltenyi Biotec; Olympus Corporation; Agilent Technologies; Merck KGaA; General Electric; Dickinson and Company; Becton; Thermo Fisher Scientific; and Danaher. |
Market Segment Insights
The flow cytometry segment held a major market share in 2021
Based on techniques, the market is segregated into high content screening, spectrophotometry, microscopy, cell microarrays, PCR, flow cytometry, and others. The flow cytometry segment held a major market share in 2021. Flow cytometry's widespread use in single-cell analysis is due to its ability to measure several parameters in a heterogeneous sample at the single-cell level, which is estimated to drive the market. The high content screening segment is anticipated to expand at a high CAGR during the forecast period. Increase in cell behavior studies is expected to boost the market. Complexity of cell image collecting and analysis workflows caused by fluorescent illumination is projected to hamper the segment growth.
The software segment is anticipated to expand at a high CAGR during the forecast period
On the basis of products & services, the market is fragmented into service, software, accessories, instruments, and reagents & consumables. The software segment is anticipated to expand at a high CAGR during the forecast period. The growing requirement for computational methodologies and software tools has resulted from the development of datasets with complicated designs and many modalities. The reagents & consumables segment accounted for a major market share in 2021. Flow cytometry reagents are available as direct conjugated products from major market vendors. Introduction of high-quality reagents by key players has boosted the market availability of dry flow cytometry reagents, resulting in the reagents & consumables industry's domination.
The single-cell analysis segment is projected to grow at a rapid pace during the forecast period
In terms of process, the market is divided into single-cell analysis, target identification & validation, cell structure study, cell interaction, cell counting & quality control, cell proliferation, cell signaling pathways/signal transduction, cell viability, and cell identification. The cell identification segment accounted for key market share in 2021. Cell identification is a crucial stage in a variety of industrial applications, such as healthcare and food. Identification of cells is crucial when it comes to medication development, cells are identified depending on how they react to a given molecule. The single-cell analysis segment is projected to grow at a rapid pace during the forecast period. Over the years, single-cell analysis has acquired a lot of popularity as a way to examine individual cells on a multi-parametric level, thus driving the market growth.
The pharmaceutical & biotechnology companies segment held a major market share in 2021
Based on end-users, the market is segregated into academic & research institutes, hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment held a major market share in 2021. The widespread usage of instruments and consumables at various phases of drug research & development is estimated to drive the segment.
North America dominated the market in 2021
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America dominated the market in 2021. Growth of the market in the region is attributed to favorable business climate, well-established biotechnology & pharmaceutical companies, strong government support, and favorable business environment. Asia Pacific is anticipated to register a high CAGR during the forecast period. The GDPs as well as their disposable incomes of Asia Pacific countries, are growing steadily, which is anticipated to fuel the market.
Segments
The global cell analysis market has been segmented on the basis of
Techniques- High Content Screening
- Spectrophotometry
- Microscopy
- Cell Microarrays
- PCR
- Flow Cytometry
- Others
- Service
- Software
- Accessories
- Instruments
- Reagents & Consumables
- Single-Cell Analysis
- Target Identification & Validation
- Cell Structure Study
- Cell Interaction
- Cell Counting & Quality Control
- Cell Proliferation
- Cell Signaling Pathways/Signal Transduction
- Cell Viability
- Cell Identification
- Academic & Research Institutes
- Hospitals & Clinical Testing Laboratories
- Pharmaceutical & Biotechnology Companies
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Illumina
- 10x Genomics
- Corning Incorporated
- QIAGEN
- CELLINK
- Tecan Trading AG
- PerkinElmer
- Promega Corporation
- Meiji Techno
- Creative Bioarray
- Cell Biolabs
- NanoCellect Biomedical
- Fluidigm Corporation
- BioStatus Limited
- Bio-Rad Laboratories
- Miltenyi Biotec
- Olympus Corporation
- Agilent Technologies
- Merck KGaA
- General Electric
- Dickinson and Company
- Becton
- Thermo Fisher Scientific
- Danaher
Competitive Landscape
Key players competing in the cell analysis market include Illumina; 10x Genomics; Corning Incorporated; QIAGEN; CELLINK; Tecan Trading AG; PerkinElmer; Promega Corporation; Meiji Techno; Creative Bioarray; Cell Biolabs; NanoCellect Biomedical; Fluidigm Corporation; BioStatus Limited; Bio-Rad Laboratories; Miltenyi Biotec; Olympus Corporation; Agilent Technologies; Merck KGaA; General Electric; Dickinson and Company; Becton; Thermo Fisher Scientific; and Danaher. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,
- In 2022, Becton, Dickinson and Company have introduced a new high-throughput cell separator that combines fluorescence and visual imaging.
- In 2020, the phitonex, inc. was acquired by Thermo Fisher Scientific. This acquisition helped Thermo Fisher Scientific company to increase its imaging multiplexing and flow cytometry capabilities in cell and protein analysis research.
Frequently Asked Questions
North America dominated the cell analysis market in 2021.
Complex and time-consuming regulatory standards are anticipated to hinder the cell analysis market growth.
The cell analysis market size was valued at USD 17.7 billion in 2021.
The cell analysis market is projected to reach USD 28.9 billion by 2030.
The cell analysis market is estimated to expand at a CAGR of around 10% during the forecast period, 2022 – 2030.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Cell Analysis Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cell Analysis Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cell Analysis Market - Supply Chain
4.5. Global Cell Analysis Market Forecast
4.5.1. Cell Analysis Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cell Analysis Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cell Analysis Market Absolute $ Opportunity
5. Global Cell Analysis Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Cell Analysis Market Size and Volume Forecast by End Users
5.3.1. Academic & Research Institutes
5.3.2. Hospitals & Clinical Testing Laboratories
5.3.3. Pharmaceutical & Biotechnology Companies
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Cell Analysis Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Cell Analysis Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Cell Analysis Demand Share Forecast, 2019-2026
7. North America Cell Analysis Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Cell Analysis Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Cell Analysis Market Size and Volume Forecast by End Users
7.4.1. Academic & Research Institutes
7.4.2. Hospitals & Clinical Testing Laboratories
7.4.3. Pharmaceutical & Biotechnology Companies
7.4.4. Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Cell Analysis Demand Share Forecast, 2019-2026
8. Latin America Cell Analysis Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Cell Analysis Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Cell Analysis Market Size and Volume Forecast by End Users
8.4.1. Academic & Research Institutes
8.4.2. Hospitals & Clinical Testing Laboratories
8.4.3. Pharmaceutical & Biotechnology Companies
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Cell Analysis Demand Share Forecast, 2019-2026
9. Europe Cell Analysis Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Cell Analysis Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Cell Analysis Market Size and Volume Forecast by End Users
9.4.1. Academic & Research Institutes
9.4.2. Hospitals & Clinical Testing Laboratories
9.4.3. Pharmaceutical & Biotechnology Companies
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Cell Analysis Demand Share Forecast, 2019-2026
10. Asia Pacific Cell Analysis Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Cell Analysis Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Cell Analysis Market Size and Volume Forecast by End Users
10.4.1. Academic & Research Institutes
10.4.2. Hospitals & Clinical Testing Laboratories
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Cell Analysis Demand Share Forecast, 2019-2026
11. Middle East & Africa Cell Analysis Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Cell Analysis Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Cell Analysis Market Size and Volume Forecast by End Users
11.4.1. Academic & Research Institutes
11.4.2. Hospitals & Clinical Testing Laboratories
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Cell Analysis Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Cell Analysis Market: Market Share Analysis
12.2. Cell Analysis Distributors and Customers
12.3. Cell Analysis Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Illumina
12.4.2. 10x Genomics
12.4.3. Corning Incorporated
12.4.4. QIAGEN
12.4.5. CELLINK
12.4.6. Tecan Trading AG
12.4.7. PerkinElmer
12.4.8. Promega Corporation
Methodology
Related Reports
Some other reports from this category!
Our Clients
